Dr. Jeffrey Weitzel on Overcoming Resistance With Combination Therapy

Optimizing combination therapies to overcome PARP inhibitor resistanceПодробнее

4th International LFS Association Symposium: Session 4 – Dr. Jeffrey WeitzelПодробнее

Developing Precision Combination Therapies to Overcome Evolution of Therapeutic ResistanceПодробнее

Jeffrey N. Weitzel, MD: The BRCA Mutation and Cancer GeneticsПодробнее

Jeffrey Settleman, Ph.D., The Many Flavors of Resistance To Anti-Cancer DrugsПодробнее

Combination Therapies to Overcome Resistance in mRCCПодробнее

Dr. Jeff Sharman: A discussion about combination therapyПодробнее

Dr. Jeffrey Weitzel on Combination Therapies in Metastatic Breast CancerПодробнее

Dr. Jeffrey Weitzel on Synthetic Lethality in BRCA-Associated CancerПодробнее

The Power of Combination Drug Therapy for Ovarian Cancer | Dana-Farber Cancer InstituteПодробнее

07-Developing Resistance - Interview with Dr. Jeffrey EnglemanПодробнее

Jeffrey N. Weitzel, MD: Cancer Genetics and AnthropologyПодробнее

Finding Prevention and a CureПодробнее

Jeffrey Weitzel - Keynote - Establishing an economic BRCA1 and BRCA2 BRCA gene analyses ...Подробнее

Day 3 - acquired resistance to FGFR inhibitorsПодробнее

Michael Gillette - Cancer Proteogenomics and Therapy ResistanceПодробнее

Overcoming the challenge of resistance to targeted therapies in CLLПодробнее

Industry view of targeted therapy combinations in oncologyПодробнее

Overcoming resistance to PARP inhibition in ovarian cancerПодробнее